title: Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual.
authors.affiliation: Division of Hematology, Department of Medicine, Shengjing Hospital affiliated with China Medical University, Shenyang, People's Republic of China.|Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Bin
authors.initials: B
authors.lastname: Wu
authors.affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Ingersoll
authors.affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Catherine
authors.initials: C
authors.lastname: Rehder
authors.affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Siby
authors.initials: S
authors.lastname: Sebastian
authors.affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA. endi.wang@duke.edu.|Department of Pathology, DUMC Box 3712, M-345 Davison Bldg (Green Zone), Duke Hospital South, Durham, NC, 27710, USA. endi.wang@duke.edu.
authors.forename: Endi
authors.initials: E
authors.lastname: Wang
mesh_terms: D002999:Clone Cells / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D003131:Combined Modality Therapy; D004358:Drug Therapy / Q000379:methods; D005838:Genotype; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000235:genetics / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000235:genetics / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods